1-2 of 2 results for subject:"Statutory sick pay"
Librarians' tools
- Search time
- 0.146 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Statutory sick pay"
- We searched for
- subject_t:"Statutory sick pay" OR subject_ses:13044
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Work and Pensions, what estimate she has made of the annual cost to businesses of paying statutory sick pay at its current rate of £95.85 a week.
To ask the Secretary of State for Work and Pensions, what estimate she has made of the annual cost to businesses of paying statutory sick pay at its current rate of £95.85 a week.
The estimated cost to employers of SSP is £1.5 billion a year. This is based on survey data from 2011. Data is not available on the total amount of SSP currently paid each year.
To ask the Secretary of State for Work and Pensions, with reference to the Chancellor of the Exchequer's oral contribution, Official Report, 11 March 2020 col 280, what the evidential basis was for the Government's commitment to reimburse businesses with fewer than 250 employees for statutory sick pay costs in...
To ask the Secretary of State for Work and Pensions, with reference to the Chancellor of the Exchequer's oral contribution, Official Report, 11 March 2020 col 280, what the evidential basis was for the Government's commitment to reimburse businesses with fewer than 250 employees for statutory sick pay costs in...
The government recognises that small and medium enterprises (SMEs) may need financial support where they incur additional costs of paying Statutory Sick Pay (SSP) due to increased absences relating to Covid-19. Under the Statutory Sick Pay Rebate Scheme, SMEs can reclaim up to two weeks of SSP per employee paid for sickness absences relating to Covid-19.
A range of costings were carried out in March 2020 based on the situation at the time. This was prior to the Coronavirus Job Retention Scheme being developed.
We will continue to revise costings based on outturn data from initial claims and the latest information about the Covid-19 outbreak.